BOSTON — April 28, 2015 — David J. Dykeman, patent attorney, co-chair of Greenberg Traurig’s Global Life Sciences & Medical Technology Group, and co-chair of the firm’s Intellectual Property (IP) Group in Boston, will present at the 83rd American Association of Neurological Surgeons (AANS) Annual Scientific Meeting, May 2-6, 2015, at the Walter E. Washington Convention Center in Washington, D.C.
From 8 a.m. – 5 p.m., May 2, Dykeman will serve as a faculty member for an all-day practical clinic on “Invention and Innovation in Neurosurgery.” This clinic will outline the process of developing, protecting, funding, and commercializing new devices and other innovations in neurosurgery, including clinical trial design, regulatory strategies, market sizing, and exit planning.
A registered patent attorney with over 18 years of experience in patents, intellectual property, and licensing, Dykeman focuses his practice on securing strategic worldwide intellectual property protection and related business strategy for high-tech clients, with particular expertise in medical devices, life sciences, biotechnology, and healthcare IT. Dykeman is the founding co-chair of the American Bar Association’s (ABA) Medical Devices Committee and serves on the Editorial Advisory Board of Medical Device + Diagnostic Industry (MD+DI) Magazine.
An author of over 45 articles and a speaker at over 40 conferences on medical devices and life sciences intellectual property, Dykeman was honored as a “Life Science Star” by LMG Life Sciences, and was named one of the top 250 Patent and Technology Licensing Practitioners in the world by Intellectual Asset Management (IAM) Magazine.
The American Association of Neurological Surgeons (AANS) is the organization that speaks for all of neurosurgery. The AANS is dedicated to advancing the specialty of neurological surgery in order to promote the highest quality of patient care.